|
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Discovery Restores Memory Loss, Reverses Symptoms of Alzheimer's"Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today." -Dr. Gerald Weissmann A new ray of hope has broken through the clouded outcomes associated with Alzheimer's disease. A new research report published in January 2013 print issue of the FASEB Journal (Federation of the American Societies for Experimental Biology) by scientists from the National Institutes of Health shows that when a molecule called TFP5 is injected into mice with disease that is the equivalent of human Alzheimer's, symptoms are reversed and memory is restored—without obvious toxic side effects.
To make this discovery, Pant and colleagues used mice with a disease considered the equivalent of Alzheimer's. One set of these mice were injected with the small molecule TFP5, while the other was injected with saline as placebo. The mice, after a series of intraperitoneal injections of TFP5, displayed a substantial reduction in the various disease symptoms along with restoration of memory loss. In addition, the mice receiving TFP5 injections experienced no weight loss, neurological stress (anxiety) or signs of toxicity. The disease in the placebo mice, however, progressed normally as expected. TFP5 was derived from the regulator of a key brain enzyme, called Cdk5. The over activation of Cdk5 is implicated in the formation of plaques and tangles, the major hallmark of Alzheimer's disease. "The next step is to find out if this molecule can have the same effects in people, and if not, to find out which molecule will," said Gerald Weissmann, M.D., Editor-in-Chief of the FASEB Journal. "Now that we know that we can target the basic molecular defects in Alzheimer's disease, we can hope for treatments far better—and more specific—than anything we have today." 
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Other Recent Articles from Breaking Christian News Prayer Alert: In Nepal, the Flood Isn't the Only Dangerous Issue for Christians There (Video) Video of Mamdani, AOC Laughing and Smiling as Names of 9/11 Victims Are Read Goes Viral (Watch) Guess Who Helped Doxx the Holdout Juror in the Lindsay Clancy Case AI Company Reports Attempts to Create Bioweapons and Malicious Cyberattacks Trump-Appointed Judge Blocks USPS Mail-Ballot Rule in Major Election Case Saved from the Ashes of 9/11, He Has Given His Life to Save Others Too: 'Call on Jesus' What the White House Faith Office Has Done in Just 18 Months A Minute By Minute Chronology of Sept. 11, 2001 Terror Attacks 100 Million Americans Have No Memory of 9/11. Here's What's on the Line |
Subscribe to
|
"We hope that clinical trial studies in AD patients should yield an extended and a better quality of life as observed in mice upon TFP5 treatment," said Harish C. Pant, Ph.D., a senior researcher involved in the work from the Laboratory of Neurochemistry at the National Institute of Neurological Disorders at Stroke at the National Institutes of Health in Bethesda, MD. "Therefore, we suggest that TFP5 should be an effective therapeutic compound." (Photo by: 
All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.
Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved
Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.
| Home | Store | Subscribe | Facebook | Article Archive |